Home | Contact | Sitemap | Search
Company
Details


"With the high-calibre investors as BASF, Bosch and Wellington Partners participating in the first financing round, Heliatek evidenced its high potential for future growth based on both deep industrial and financial understanding. This, together with the leading edge technology of Heliatek convinced me to move from Evonik, the global specialty chemicals company, to Heliatek, the technology leader in organic solar cells based on small molecules. I’m proud to work for this exciting company."

Dr. Andreas Rückemann
CEO, Heliatek

Wellington contact:
Bart Markus

Developing the next generation
of photovoltaics


Based in Dresden – in the centre of a region that possesses one of the most dynamic solar industries in the world - Heliatek is engaged in the development and production of organic solar cells, the next generation of photovoltaic technology. Founded in 2006, the joint spin-off of the University of Dresden and the University of Ulm is working on a technology to build large-scale modules on cheap, flexible substrates using a roll-to-roll production process, meanwhile maintaining efficiency at the market levels and with the lifetime required for the mass market. Heliatek started with a seed investment by the German semi-public High-Tech Gründerfonds in September 2006. Wellington invested together with strategic investors BASF (on the materials side) and Bosch (on the system-integration side) in the first institutional funding round of Heliatek in June 2007. In November 2009, Wellington Partners led a Series B round of € 18 million which is earmarked for building an initial production facility in Dresden.

First investment: June 2007

heliatek GmbH
Liebigstr. 26
01187 Dresden
Germany

www.heliatek.com
News from Heliatek

Home | What we offer | What we look for | Our Team | Our Portfolio | News | Careers | Contact | Sitemap | Terms and Conditions
Facebook
Twitter
Del.icio.us
Linkarena
Digg
Webnews
Google
Technorati
Mister Wong
Yahoo
Yigg
  © by Wellington Partners Venture Capital